Zinc oxide nanoparticles modulate the gene expression of ZnT1 and ZIP8 to manipulate zinc homeostasis and stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells
Open Access
- 11 September 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (9) , e0232729
Abstract
Zinc ions (Zn2+) are important messenger molecules involved in various physiological functions. To maintain the homeostasis of cytosolic Zn2+ concentration ([Zn2+]c), Zrt/Irt-related proteins (ZIPs) and Zn2+ transporters (ZnTs) are the two families of proteins responsible for decreasing and increasing the [Zn2+]c, respectively, by fluxing Zn2+ across the membranes of the cell and intracellular compartments in opposite directions. Most studies focus on the cytotoxicity incurred by a high concentration of [Zn2+]c and less investigate the [Zn2+]c at physiological levels. Zinc oxide-nanoparticle (ZnO-NP) is blood brain barrier-permeable and elevates the [Zn2+]c to different levels according to the concentrations of ZnO-NP applied. In this study, we mildly elevated the [Zn2+]c by ZnO-NP at concentrations below 1 μg/ml, which had little cytotoxicity, in cultured human neuroblastoma SH-SY5Y cells and characterized the importance of Zn2+ transporters in 6-hydroxy dopamine (6-OHDA)-induced cell death. The results show that ZnO-NP at low concentrations elevated the [Zn2+]c transiently in 6 hr, then declined gradually to a basal level in 24 hr. Knocking down the expression levels of ZnT1 (located mostly at the plasma membrane) and ZIP8 (present in endosomes and lysosomes) increased and decreased the ZnO-NP-induced elevation of [Zn2+]c, respectively. ZnO-NP treatment reduced the basal levels of reactive oxygen species and Bax/Bcl-2 mRNA ratios; in addition, ZnO-NP decreased the 6-OHDA-induced ROS production, p53 expression, and cell death. These results show that ZnO-NP-induced mild elevation in [Zn2+]c activates beneficial effects in reducing the 6-OHDA-induced cytotoxic effects. Therefore, brain-delivery of ZnO-NP can be regarded as a potential therapy for neurodegenerative diseases.Keywords
All Related Versions
Funding Information
- Ministry of Science and Technology, Taiwan (102-2320-B-031-001)
- Ministry of Science and Technology, Taiwan (104-2622-B-031-001-CC2)
- Ministry of Science and Technology, Taiwan (104-2632-B-031-001)
- Ministry of Science and Technology, Taiwan (107-2320-B-002-052)
This publication has 48 references indexed in Scilit:
- The Role of Metallothionein in Oxidative StressInternational Journal of Molecular Sciences, 2013
- Zinc homeostasis and neurodegenerative disordersFrontiers in Aging Neuroscience, 2013
- Neuroprotective Effects of Reactive Oxygen Species Mediated by BDNF-Independent Activation of TrkBJournal of Neuroscience, 2012
- Development of Novel Zn2+ Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro EvidencesPLOS ONE, 2011
- Zinc and Neurogenesis: Making New Neurons from Development to AdulthoodAdvances in Nutrition, 2011
- Modulation of Neuronal Signal Transduction and Memory Formation by Synaptic ZincFrontiers in Behavioral Neuroscience, 2011
- Zinc and Zinc Transporter Regulation in Pancreatic Islets and the Potential Role of Zinc in Islet TransplantationThe Review of Diabetic Studies, 2010
- Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-γ expression in activated human T cellsJournal of Leukocyte Biology, 2009
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994